Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer

Satheesh Krishna1, Christopher S Lim1, Matthew D F McInnes1

  • 1Department of Medical Imaging, Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.

Abstract

Insights

Magnetic resonance imaging (MRI) can help diagnose extraprostatic extension (EPE) in prostate cancer. Tumor size, capsular contact, and ADC entropy improve sensitivity but decrease specificity compared to subjective assessment.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Background:

  • Accurate diagnosis of extraprostatic extension (EPE) is crucial for prostate cancer management.
  • Magnetic resonance imaging (MRI) is increasingly used for prostate cancer staging.

Purpose of the Study:

  • To evaluate the diagnostic performance of 3T MRI in detecting extraprostatic extension (EPE) in prostate cancer.
  • To compare the efficacy of subjective assessment, PI-RADS v2, tumor size, length of capsular contact (LCC), and apparent diffusion coefficient (ADC) metrics for EPE diagnosis.

Main Methods:

  • 149 men with prostate cancer underwent preoperative 3T MRI before radical prostatectomy.
  • Two radiologists subjectively assessed for EPE and measured tumor size and LCC.
  • A third radiologist measured whole-lesion ADC metrics.
  • Statistical analyses included chi-square, logistic regression, and ROC analysis.

Main Results:

  • Subjective EPE assessment showed high specificity but low sensitivity.
  • PI-RADS v2 scores were associated with EPE.
  • Tumor size and LCC were significantly larger in tumors with EPE.
  • ADC entropy showed good diagnostic performance (AU-ROC=0.76).
  • Size, LCC, and ADC entropy improved sensitivity but reduced specificity compared to subjective assessment.

Conclusions:

  • Measurements of tumor size, LCC, and ADC entropy enhance the sensitivity of MRI for detecting EPE.
  • These quantitative MRI features decrease specificity when used for EPE diagnosis.
  • Combined quantitative and subjective MRI assessments may optimize EPE detection in prostate cancer.